Job A J Verdonschot1,2, Mark R Hazebroek1, Kasper W J Derks1,2, Arantxa Barandiarán Aizpurua1, Jort J Merken1, Ping Wang2, Jörgen Bierau2, Arthur van den Wijngaard2, Simon M Schalla1,3, Myrurgia A Abdul Hamid4, Marc van Bilsen1, Vanessa P M van Empel1, Christian Knackstedt1, Hans-Peter Brunner-La Rocca1, Han G Brunner2,5, Ingrid P C Krapels2, Stephane R B Heymans1,6,7. 1. Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands. 2. Department of Clinical Genetics and School for Oncology & Developmental Biology (GROW), Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands. 3. Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debeylaan 25, 6229 HX Maastricht, The Netherlands. 4. Department of Pathology, Maastricht University Medical Centre, P. Debeylaan 25, 6229 HX Maastricht, The Netherlands. 5. Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, 6500 GA, The Netherlands. 6. Department of Cardiovascular Research, University of Leuven, UZ Herestraat 49, 3000 Leuven, Belgium. 7. Netherlands Heart Institute (ICIN), Moreelsepark 1, 3511 EP Utrecht, The Netherlands.
Abstract
Aims: Truncating titin variants (TTNtv) are the most prevalent genetic cause of dilated cardiomyopathy (DCM). We aim to study clinical parameters and long-term outcomes related to the TTNtv genotype and determine the related molecular changes at tissue level in TTNtv DCM patients. Methods and results: A total of 303 consecutive and extensively phenotyped DCM patients (including cardiac imaging, Holter monitoring, and endomyocardial biopsy) underwent DNA sequencing of 47 cardiomyopathy-associated genes including TTN, yielding 38 TTNtv positive (13%) patients. At long-term follow-up (median of 45 months, up to 12 years), TTNtv DCM patients had increased ventricular arrhythmias compared to other DCM, but a similar survival. Arrhythmias are especially prominent in TTNtv patients with an additional environmental trigger (i.e. virus infection, cardiac inflammation, systemic disease, toxic exposure). Importantly, cardiac mass is reduced in TTNtv patients, despite similar cardiac function and dimensions at cardiac magnetic resonance. These enhanced life-threatening arrhythmias and decreased cardiac mass in TTNtv DCM patients go along with significant cardiac energetic and matrix alterations. All components of the mitochondrial electron transport chain are significantly upregulated in TTNtv hearts at RNA-sequencing. Also, interstitial fibrosis was augmented in TTNtv patients at histological and transcript level. Conclusion: Truncating titin variants lead to pronounced cardiac alterations in mitochondrial function, with increased interstitial fibrosis and reduced hypertrophy. Those structural and metabolic alterations in TTNtv hearts go along with increased ventricular arrhythmias at long-term follow-up, with a similar survival and overall cardiac function.
Aims: Truncating titin variants (TTNtv) are the most prevalent genetic cause of dilated cardiomyopathy (DCM). We aim to study clinical parameters and long-term outcomes related to the TTNtv genotype and determine the related molecular changes at tissue level in TTNtvDCMpatients. Methods and results: A total of 303 consecutive and extensively phenotyped DCMpatients (including cardiac imaging, Holter monitoring, and endomyocardial biopsy) underwent DNA sequencing of 47 cardiomyopathy-associated genes including TTN, yielding 38 TTNtv positive (13%) patients. At long-term follow-up (median of 45 months, up to 12 years), TTNtvDCMpatients had increased ventricular arrhythmias compared to other DCM, but a similar survival. Arrhythmias are especially prominent in TTNtvpatients with an additional environmental trigger (i.e. virus infection, cardiac inflammation, systemic disease, toxic exposure). Importantly, cardiac mass is reduced in TTNtvpatients, despite similar cardiac function and dimensions at cardiac magnetic resonance. These enhanced life-threatening arrhythmias and decreased cardiac mass in TTNtvDCMpatients go along with significant cardiac energetic and matrix alterations. All components of the mitochondrial electron transport chain are significantly upregulated in TTNtv hearts at RNA-sequencing. Also, interstitial fibrosis was augmented in TTNtvpatients at histological and transcript level. Conclusion: Truncating titin variants lead to pronounced cardiac alterations in mitochondrial function, with increased interstitial fibrosis and reduced hypertrophy. Those structural and metabolic alterations in TTNtv hearts go along with increased ventricular arrhythmias at long-term follow-up, with a similar survival and overall cardiac function.
Authors: Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans Journal: Cardiovasc Res Date: 2018-08-01 Impact factor: 10.787
Authors: Christopher M Haggerty; Scott M Damrauer; Michael G Levin; David Birtwell; David J Carey; Alicia M Golden; Dustin N Hartzel; Yirui Hu; Renae Judy; Melissa A Kelly; Rachel L Kember; H Lester Kirchner; Joseph B Leader; Lusha Liang; Chris McDermott-Roe; Apoorva Babu; Michael Morley; Zachariah Nealy; Thomas N Person; Arichanah Pulenthiran; Aeron Small; Diane T Smelser; Richard C Stahl; Amy C Sturm; Heather Williams; Aris Baras; Kenneth B Margulies; Thomas P Cappola; Frederick E Dewey; Anurag Verma; Xinyuang Zhang; Adolfo Correa; Michael E Hall; James G Wilson; Marylyn D Ritchie; Daniel J Rader; Michael F Murray; Brandon K Fornwalt; Zoltan Arany Journal: Circulation Date: 2019-06-20 Impact factor: 29.690
Authors: Tomas Robyns; Rik Willems; Johan Van Cleemput; Shalini Jhangiani; Donna Muzny; Richard Gibbs; James R Lupski; Jeroen Breckpot; Koenraad Devriendt; Anniek Corveleyn Journal: Acta Cardiol Date: 2019-10-04 Impact factor: 1.718
Authors: A Paldino; G De Angelis; M Merlo; M Gigli; M Dal Ferro; G M Severini; L Mestroni; G Sinagra Journal: Curr Cardiol Rep Date: 2018-08-13 Impact factor: 2.931